Eve & Co Completes its Largest to Date Shipment of Cannabis to Germany

STRATHROY, Ontario, Aug. 11, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce that it has, through its wholly-owned subsidiary Natural MedCo Ltd. (“NMC”), successfully completed its largest shipment of cannabis to a customer in Germany with a retail value of $1.8M CAD. Eve & Co received its European Union certificate of Good Manufacturing Practice (“EU-GMP certification”) in March of 2020, undertook the required shipments for scientific purposes in the summer of 2020 and has continued to complete regular commercial shipments to its customers in Germany since the fourth quarter of 2020.

Eve & Co is one of a select few licensed facilities in Canada which is EU-GMP certified and able to export cannabis into the emerging and growing cannabis markets of the EU. The Company’s 1,000,000 square foot greenhouse facility is located in Strathroy, Ontario and is one of the largest cannabis facilities in Canada and one of the largest EU-GMP certified cannabis facilities in the world. Eve & Co has supply agreements with ten (10) German companies for distribution of product throughout the EU.

“Our export quantities to Germany have been continually increasing as has the demand for our EU-GMP certified product by our German partners. Our EU-GMP certification provides a competitive advantage in that we are not solely reliant for revenue on the over-supplied Canadian market. We can establish our product in international markets and continually increase exports to these developing markets through our partners as their businesses grow,” said Melinda Rombouts, President and Chief Executive Officer of Eve & Co.

About Eve & Co Incorporated

Eve & Co, through its wholly owned subsidiary NMC, holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received its EU-GMP certificate. NMC was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario.

The Company’s website can be visited at www.evecannabis.ca.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding forward looking statements:

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur, and include, but are not limited to, the production and sale of bath bombs by the Company, whether sales of bath bombs will occur, if any at all, or recur and the timing thereof. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guaranteeing of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s management’s discussion and analysis dated May 31, 2021 (the “MD&A”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. The Company cautions that the list of risks, uncertainties and other factors described in the MD&A is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

For further information, please contact:

Melinda Rombouts
President and Chief Executive Officer
Eve & Co Incorporated
Telephone: (855) 628-6337

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.